Thanks for the speedy reply. One of the mnotable properties of NAC is it's decongestant effect. In tandem with MPL which is destroying the virus, one could potentially reduce the severity of the symptoms while MPL goes to the source. Sounds like a win-win to me.
I hope it is on the radar for the upcoming trial.
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III, page-584
-
- There are more pages in this discussion • 883 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.005(3.13%) |
Mkt cap ! $80.22M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 17.5¢ | 16.5¢ | $276.1K | 1.636M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 379426 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |